Singapore-headquartered private equity (PE) firm Quadria Capital is in advanced talks to invest in India’s Maxivision Super Speciality Eye Hospitals, run by serial healthcare entrepreneur GSK Velu, in a deal that will value the firm at about Rs 1200 crore ($145 million).
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
